Related Experiment Video
Updated: Feb 27, 2026

Live-cell Imaging of Lysosomal Membrane Permeabilization During Necroptosis
Published on: November 14, 2025
Necroptosis in cancer: An angel or a demon?
Tianzhen Wang1, Yinji Jin1, Weiwei Yang1
11 Department of Pathology, Harbin Medical University, Harbin, China.
Abstract:
In the past few decades, apoptosis has been regarded as the only form of programmed cell death. However, the traditional view has been challenged by the identification of several forms of regulated necrosis, including necroptosis. Necroptosis is typified by a necrotic cell death morphology and is controlled by RIP1, RIP3, and mixed lineage kinase domain-like protein. The physiological role of necroptosis is to serve as a "fail-safe" form of cell death for cells that fail to undergo apoptosis during embryonic development and disease defense. Currently, established studies have indicated that necroptosis is involved in cancer initiation and progression. Although elevated necroptosis contributes to cancer cell death, extensive cell death also increases the risk of proliferation and metastasis of the surviving cells by inducing the generation reactive oxygen species, activation of inflammation, and suppression of the immune response. Thus, questions regarding the overall impact of necroptosis on cancer remain open. In this review, we introduce the basic knowledge regarding necroptosis, summarize its dual effects on cancer progression, and analyze its advantages and disadvantages in clinical applications.
Insights
Necroptosis, a regulated necrosis, plays a dual role in cancer. While it can induce cancer cell death, it may also promote proliferation and metastasis in surviving cells.
Area of Science:
- Cell Biology
- Oncology
- Immunology
Background:
- Apoptosis was historically considered the sole programmed cell death pathway.
- Necroptosis, a regulated necrosis, has emerged as a critical alternative cell death mechanism.
- Key regulators of necroptosis include RIPK1, RIPK3, and MLKL.
Purpose of the Study:
- To review the fundamental mechanisms of necroptosis.
- To elucidate the multifaceted role of necroptosis in cancer development and progression.
- To analyze the clinical implications and therapeutic potential of targeting necroptosis in cancer.
Main Methods:
- Literature review of necroptosis research.
- Analysis of studies investigating necroptosis in cancer initiation, progression, and metastasis.
- Evaluation of necroptosis-associated biomarkers and therapeutic strategies.
Main Results:
- Necroptosis acts as a "fail-safe" cell death mechanism, crucial for development and immunity.
- Elevated necroptosis can paradoxically promote cancer by inducing inflammation, ROS generation, and immune suppression in surviving cells.
- The net effect of necroptosis on cancer is complex, with both tumor-suppressive and tumor-promoting roles.
Conclusions:
- Necroptosis presents a complex interplay with cancer, offering both challenges and opportunities for therapy.
- Understanding the dual role of necroptosis is essential for developing effective cancer treatments.
- Targeting necroptosis pathways may offer novel therapeutic avenues, but requires careful consideration of context-dependent effects.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway

